PNOC014: Phase I Study of Tovorafenib for Children With Relapsed/Recurrent Low-Grade Gliomas and Other Mitogen Activated Protein Kinase Pathway–Activated Tumors
Karen Wright(Boston Children's Hospital), Sabine Mueller(University of California, San Francisco), Lianne Greenspan(Dana-Farber Cancer Institute), David H. Ebb(Harvard University Press), Keith L. Ligon(Brigham and Women's Hospital), Erin Crotty(Seattle Children's Hospital), Lindsay Kilburn(Children's National), Michael D. Prados(University of California, San Francisco), Eric H. Raabe(Johns Hopkins University), Cassie Kline(Children's Hospital of Philadelphia), Matthew B. Miller(Doernbecher Children's Hospital), Susan Chi(Harvard University), Daphne A. Haas‐Kogan(Brigham and Women's Hospital), Clement Ma(University of Toronto), Mohamed S Abdelbaki(Nationwide Children's Hospital), Pei-Chi Kao(Boston Children's Hospital), Jennifer Elster, Jacquelyn Jones(Dana-Farber Cancer Institute), Elias Sayour(University of Florida), Emily S. Krzykwa(Dana-Farber Cancer Institute), Ashley Margol(University of Southern California), Anne E. Bendel(Minnesota West Community & Technical College), Wendy B. London(Dana-Farber Cancer Institute)
Cited by 0
Related Papers
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Epidermal growth factor receptor and Ink4a/Arf
|Cancer Cell|2002|647
A large peptidome dataset improves HLA class I epitope prediction across most of the human population
|Nature Biotechnology|2019|539
Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy
|Science Translational Medicine|2013|510